Orthocoronavirinae infectious disease
Orthocoronavirinae infectious disease
Explore linked clinical trials. Standard reference: MONDO:0020753565 results · Page 1 of 23
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-10-09 | NCT07743580 | |
| A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07703475 | |
| A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 | 2026-10-09 | NCT07536308 | |
| Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07388550 | |
| Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI) | COVID-19, Coronaviridae Infections, Infections, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paraosmia, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rhinosinusitis, Sensation Disorders, Signs and Symptoms, anosmia, depressive disorder, influenza, lung disorder, nasal disorder, nervous system disorder, otorhinolaryngologic disease, paranasal sinus disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rhinitis, sinusitis, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-09 | NCT07149428 | |
| A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-10-09 | NCT06672055 | |
| The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients | COVID-19, Coronaviridae Infections, Critical Illness, Disease Attributes, Infections, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, lung disorder, nutritional deficiency disease, nutritional disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia, vitamin D deficiency, vitamin deficiency disorder | Active, not recruiting | Phase 3 | 2026-10-09 | NCT03188796 | |
| A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 4 | 2026-10-07 | NCT07863635 | |
| IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Inflammation, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, depressive disorder, long COVID-19, lung disorder, major depressive disorder, mood disorder, nervous system disorder, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2026-10-07 | NCT07197138 | |
| COMMUNITY - the COVID-19 Immunity Study | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-10-07 | NCT06784739 | |
| Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-07 | NCT04582903 | |
| Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic | COVID-19, Coronaviridae Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Skin and Connective Tissue Diseases, lung disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, pneumonia, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin neoplasm, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-07 | NCT04474301 | |
| NCI COVID-19 in Cancer Patients, NCCAPS Study | COVID-19, Coronaviridae Infections, Infections, Neoplasm Metastasis, Neoplastic Processes, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, lung disorder, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-10-07 | NCT04387656 | |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery | COVID-19, Coronaviridae Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, adenocarcinoma, breast carcinoma in situ, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, hereditary breast carcinoma, in situ carcinoma, invasive breast carcinoma, lung disorder, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-07 | NCT04169542 | |
| Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 4 | 2026-10-06 | NCT07861542 | |
| Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not applicable | 2026-10-06 | NCT07743970 | |
| PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2026-10-06 | NCT07661862 | |
| Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 | 2026-10-06 | NCT07093580 | |
| Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-10-06 | NCT06928272 | |
| A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-10-05 | NCT06667700 | |
| Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia | COVID-19, Coronaviridae Infections, Hemic and Lymphatic Diseases, Infections, Neoplasms by Site, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, lung disorder, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT04565665 | |
| Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-05 | NCT04448145 | |
| Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer | COVID-19, Coronaviridae Infections, Infections, Neoplasms by Site, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, lung disorder, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, skin disorder, triple-negative breast carcinoma, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-10-02 | NCT07856225 | |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Respiration Disorders, adult acute respiratory distress syndrome, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, severe acute respiratory syndrome, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-10-02 | NCT05624450 | |
| Exercise in Child Health | COVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Digestive System Diseases, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, anemia, cystic fibrosis, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, lung disorder, pancreas disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, sickle cell disease, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2026-10-02 | NCT05359991 |